Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213392171> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W4213392171 endingPage "S81" @default.
- W4213392171 startingPage "S75" @default.
- W4213392171 abstract "This multicenter study is the first one on Iranian children with very early onset ulcerative colitis (UC) and one of the few studies about the effect of biological therapy in children with UC under 7 years of age.Children with very early onset inflammatory bowel disease (IBD) are diagnosed before 6 years of age.The current study was performed on 14 children under 7 years of age with severe UC. Children with severe UC whose therapy with corticosteroid and azathioprine as conventional treatment had failed were treated with infliximab (IFX) and later with adalimumab (ADA).Among the total 14 participants, 6 (43%) patients were female. Mean patient age was 4.9 years (range = 3-7 years), mean age at diagnosis was 3.4 years (range = 1.5-6 years), and mean duration of illness was 1.5 years. At the end of 54 weeks of therapy with IFX, 2 (14%) patients were in remission, 2 (14%) patients were mild, and 4 (29%) patients were moderate, with no secondary treatment failure (during the maintenance phase). A total of 6 (43%) patients had primary treatment failure (no response after 14 weeks of therapy). These patients were treated with ADA. At the end of 52 weeks of therapy, 3 (50%) of those 6 (100%) patients were referred for colectomy, 1 (17%) was in remission, and 2 (33%) patients had mild severity.The current study has shown that IFX is a safe and effective therapy for children with very early onset UC. ADA may be effective in the treatment of children with UC who are refractory to IFX." @default.
- W4213392171 created "2022-02-24" @default.
- W4213392171 creator A5004425214 @default.
- W4213392171 creator A5014414667 @default.
- W4213392171 creator A5060066308 @default.
- W4213392171 creator A5078007832 @default.
- W4213392171 creator A5085910940 @default.
- W4213392171 date "2021-01-01" @default.
- W4213392171 modified "2023-09-28" @default.
- W4213392171 title "Efficacy of infliximab and adalimumab therapy in very early onset, severe ulcerative colitis." @default.
- W4213392171 cites W1990696193 @default.
- W4213392171 cites W2022077807 @default.
- W4213392171 cites W2024991605 @default.
- W4213392171 cites W2439824331 @default.
- W4213392171 cites W2781618914 @default.
- W4213392171 cites W2807688850 @default.
- W4213392171 cites W2892743283 @default.
- W4213392171 cites W2941983942 @default.
- W4213392171 cites W2998419708 @default.
- W4213392171 cites W3041200452 @default.
- W4213392171 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35154605" @default.
- W4213392171 hasPublicationYear "2021" @default.
- W4213392171 type Work @default.
- W4213392171 citedByCount "0" @default.
- W4213392171 crossrefType "journal-article" @default.
- W4213392171 hasAuthorship W4213392171A5004425214 @default.
- W4213392171 hasAuthorship W4213392171A5014414667 @default.
- W4213392171 hasAuthorship W4213392171A5060066308 @default.
- W4213392171 hasAuthorship W4213392171A5078007832 @default.
- W4213392171 hasAuthorship W4213392171A5085910940 @default.
- W4213392171 hasConcept C126322002 @default.
- W4213392171 hasConcept C141071460 @default.
- W4213392171 hasConcept C187212893 @default.
- W4213392171 hasConcept C2776667177 @default.
- W4213392171 hasConcept C2776760755 @default.
- W4213392171 hasConcept C2777138892 @default.
- W4213392171 hasConcept C2777767895 @default.
- W4213392171 hasConcept C2778260677 @default.
- W4213392171 hasConcept C2779134260 @default.
- W4213392171 hasConcept C2780132546 @default.
- W4213392171 hasConcept C2780479503 @default.
- W4213392171 hasConcept C71924100 @default.
- W4213392171 hasConceptScore W4213392171C126322002 @default.
- W4213392171 hasConceptScore W4213392171C141071460 @default.
- W4213392171 hasConceptScore W4213392171C187212893 @default.
- W4213392171 hasConceptScore W4213392171C2776667177 @default.
- W4213392171 hasConceptScore W4213392171C2776760755 @default.
- W4213392171 hasConceptScore W4213392171C2777138892 @default.
- W4213392171 hasConceptScore W4213392171C2777767895 @default.
- W4213392171 hasConceptScore W4213392171C2778260677 @default.
- W4213392171 hasConceptScore W4213392171C2779134260 @default.
- W4213392171 hasConceptScore W4213392171C2780132546 @default.
- W4213392171 hasConceptScore W4213392171C2780479503 @default.
- W4213392171 hasConceptScore W4213392171C71924100 @default.
- W4213392171 hasIssue "Suppl1" @default.
- W4213392171 hasLocation W42133921711 @default.
- W4213392171 hasOpenAccess W4213392171 @default.
- W4213392171 hasPrimaryLocation W42133921711 @default.
- W4213392171 hasRelatedWork W10433427 @default.
- W4213392171 hasRelatedWork W10740172 @default.
- W4213392171 hasRelatedWork W19646954 @default.
- W4213392171 hasRelatedWork W20399346 @default.
- W4213392171 hasRelatedWork W21382420 @default.
- W4213392171 hasRelatedWork W21450258 @default.
- W4213392171 hasRelatedWork W3760442 @default.
- W4213392171 hasRelatedWork W6153025 @default.
- W4213392171 hasRelatedWork W8001228 @default.
- W4213392171 hasRelatedWork W8387190 @default.
- W4213392171 hasVolume "14" @default.
- W4213392171 isParatext "false" @default.
- W4213392171 isRetracted "false" @default.
- W4213392171 workType "article" @default.